Regulatory press release18.06.2024, 19.00Cline Scientific: Communiqué from the Annual General Meeting
Regulatory press release26.05.2024, 09.15Annual Report for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2023
Regulatory press release30.04.2024, 10.05Cline Scientific provides an update on the company's financial position
Press release15.03.2024, 08.45BioStock: Scientific Advisor on the potential of Cline's cell therapy for cartilage damage
Press release01.03.2024, 08.30Cline: StemCART updates on achieved milestones on the way to phase 1 study
Regulatory press release23.02.2024, 08.30Bokslutskommuniké for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2023
Press release13.02.2024, 08.30Cline Scientific advisor discusses the future of cartilage damage treatment
Regulatory press release18.01.2024, 20.12Cline Scientific provides an update on the company's financial position
Press release18.01.2024, 19.15Cline Scientific provides an update on the company's financial position
Press release22.12.2023, 12.13Cline: Medtech4Health supports capacity building in the strategy and regulatory pathway for StemCART
Press release08.12.2023, 12.00CORRECTION: Newsletter December 2023 - Summing up the year with a Christmas message and Cline's bright view of the future
Press release07.12.2023, 13.03Newsletter December 2023 - Summing up the year with a Christmas message and Cline's bright view of the future
Press release21.11.2023, 11.18Judgment in the market manipulation case against Cline Scientific's CEO Patrik Sundh